{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:04:39Z","timestamp":1789574679725,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"MIUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clnu.2023.09.022","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:50:34Z","timestamp":1695606634000},"page":"2181-2187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0479-8825","authenticated-orcid":false,"given":"Nuria","family":"Perez-Diaz-del-Campo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Dileo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-1440","authenticated-orcid":false,"given":"Gabriele","family":"Castelnuovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Guariglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-9481","authenticated-orcid":false,"given":"Gian Paolo","family":"Caviglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Armandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clnu.2023.09.022_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.clnu.2023.09.022_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.clnu.2023.09.022_bib3","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/liv.15024","article-title":"Diet and exercise in NAFLD\/NASH: beyond the obvious","volume":"41","author":"Semmler","year":"2021","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clnu.2023.09.022_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.31229","article-title":"Genetic pathways in nonalcoholic fatty liver disease: insights from systems biology","volume":"72","author":"Sookoian","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.09.022_bib5","first-page":"12","article-title":"Gene-environmental interactions as metabolic drivers of nonalcoholic steatohepatitis","author":"Albhaisi","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.clnu.2023.09.022_bib6","doi-asserted-by":"crossref","DOI":"10.23736\/S0031-0808.22.04590-6","article-title":"A\u00a0nutrigenetic tool for precision dietary management of NAFLD deeming insulin resistance markers","author":"Perez-Diaz-Del-Campo","year":"2022","journal-title":"Panminerva Med"},{"key":"10.1016\/j.clnu.2023.09.022_bib7","first-page":"372","article-title":"Management of non-alcoholic fatty liver disease","author":"Petroni","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.clnu.2023.09.022_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S095442241600007X","article-title":"Current evidence on the association of the metabolic syndrome and dietary patterns in a global perspective","volume":"29","author":"Hosseini","year":"2016","journal-title":"Nutr Res Rev"},{"issue":"10","key":"10.1016\/j.clnu.2023.09.022_bib9","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/oby.22964","article-title":"A\u00a0fad too far? Dietary strategies for the prevention and treatment of NAFLD","volume":"28","author":"Moore","year":"2020","journal-title":"Obesity"},{"issue":"1\u20132","key":"10.1016\/j.clnu.2023.09.022_bib10","first-page":"43","article-title":"Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity","volume":"10","author":"Ramos-Lopez","year":"2017","journal-title":"J\u00a0Nutrigenetics Nutrigenomics"},{"issue":"12","key":"10.1016\/j.clnu.2023.09.022_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/apt.15738","article-title":"Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis","volume":"51","author":"Carlsson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.clnu.2023.09.022_bib12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.clnu.2023.09.022_bib13","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"6B","key":"10.1016\/j.clnu.2023.09.022_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1079\/PHN2002394","article-title":"European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection","volume":"5","author":"Riboli","year":"2002","journal-title":"Publ Health Nutr"},{"issue":"5","key":"10.1016\/j.clnu.2023.09.022_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.clnu.2023.09.022_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clnu.2023.09.022_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091987","article-title":"Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy","volume":"9","author":"Karlas","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.clnu.2023.09.022_bib18","first-page":"285","article-title":"Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine","volume":"25","author":"Perez-Diaz-Del-Campo","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"12","key":"10.1016\/j.clnu.2023.09.022_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12123860","article-title":"Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review","volume":"12","author":"Parra-Vargas","year":"2020","journal-title":"Nutrients"},{"issue":"17","key":"10.1016\/j.clnu.2023.09.022_bib20","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A\u00a0feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clnu.2023.09.022_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.751938","article-title":"Therapeutic targeting of nonalcoholic fatty liver disease by downregulating SREBP-1C expression via AMPK-KLF10 Axis","volume":"8","author":"Chen","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.clnu.2023.09.022_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molmet.2019.01.013","article-title":"Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice","volume":"22","author":"Lind\u00e9n","year":"2019","journal-title":"Mol Metabol"},{"issue":"6","key":"10.1016\/j.clnu.2023.09.022_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.clnu.2023.09.022_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.14218\/JCTH.2021.00286","article-title":"PNPLA3 rs738409 C>G variant influences the association between visceral fat and significant fibrosis in biopsy-proven nonalcoholic fatty liver disease","volume":"10","author":"Li","year":"2022","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"6","key":"10.1016\/j.clnu.2023.09.022_bib25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep4.1896","article-title":"Nonalcoholic fatty liver disease and associated risk factors in a community-based sample of Mexican-origin adults","volume":"6","author":"Garcia","year":"2022","journal-title":"Hepatol Commun"},{"issue":"12","key":"10.1016\/j.clnu.2023.09.022_bib26","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.cgh.2020.08.054","article-title":"Interaction between alcohol consumption and PNPLA3 variant in the prevalence of hepatic steatosis in the US population","volume":"19","author":"Lazo","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clnu.2023.09.022_bib27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.14309\/ajg.0000000000001072","article-title":"Impact of the association between PNPLA3 genetic variation and dietary intake on the risk for significant fibrosis in patients with NAFLD","volume":"116","author":"Vilar-Gomez","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.clnu.2023.09.022_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/14728222.2021.2018418","article-title":"PNPLA3 as a therapeutic target for fatty liver disease: the evidence to date","volume":"25","author":"Cherubini","year":"2021","journal-title":"Expert Opin Ther Targets"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423003114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423003114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:13:47Z","timestamp":1759367627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423003114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0261561423003114"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.09.022","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}